| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,372 |
10,656 |
$903K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,429 |
12,442 |
$854K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,363 |
4,986 |
$469K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,872 |
4,827 |
$422K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,799 |
3,764 |
$323K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,297 |
6,081 |
$254K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,017 |
2,961 |
$252K |
| 99215 |
Prolong outpt/office vis |
1,100 |
1,024 |
$107K |
| 90723 |
|
2,509 |
2,489 |
$97K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,439 |
2,404 |
$80K |
| 99381 |
|
623 |
614 |
$54K |
| 99383 |
|
529 |
526 |
$47K |
| 97802 |
|
1,674 |
1,656 |
$43K |
| 90461 |
|
1,395 |
1,382 |
$35K |
| 90707 |
|
1,547 |
1,533 |
$35K |
| 99382 |
|
349 |
346 |
$32K |
| 90648 |
|
3,158 |
3,132 |
$24K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
620 |
594 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,634 |
1,579 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,076 |
925 |
$21K |
| 90696 |
|
573 |
565 |
$18K |
| 90686 |
|
2,390 |
2,336 |
$17K |
| 90670 |
|
2,333 |
2,312 |
$17K |
| 83655 |
|
1,423 |
1,407 |
$15K |
| 99401 |
|
515 |
358 |
$14K |
| 90633 |
|
1,682 |
1,673 |
$13K |
| 90700 |
|
503 |
498 |
$12K |
| 90716 |
|
1,541 |
1,527 |
$12K |
| 96161 |
|
4,487 |
4,132 |
$12K |
| 90715 |
|
476 |
464 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
615 |
608 |
$10K |
| 90681 |
|
1,309 |
1,295 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
254 |
241 |
$9K |
| 99384 |
|
73 |
71 |
$7K |
| 90734 |
|
907 |
886 |
$7K |
| 90651 |
|
826 |
802 |
$6K |
| 99050 |
|
99 |
97 |
$5K |
| 90677 |
|
579 |
578 |
$5K |
| 92552 |
|
329 |
324 |
$4K |
| 90620 |
|
440 |
426 |
$3K |
| 99460 |
|
36 |
36 |
$3K |
| 87807 |
|
267 |
257 |
$3K |
| 85018 |
|
1,477 |
1,458 |
$3K |
| 90671 |
|
304 |
302 |
$3K |
| 0071A |
|
115 |
75 |
$3K |
| 0072A |
|
107 |
72 |
$3K |
| 99417 |
Prolong home eval add 15m |
77 |
72 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
44 |
43 |
$3K |
| 94664 |
|
135 |
122 |
$2K |
| 99188 |
|
117 |
117 |
$2K |
| 90710 |
|
45 |
44 |
$2K |
| 81025 |
|
144 |
132 |
$1K |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
264 |
255 |
$922.50 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
24 |
24 |
$770.00 |
| 81002 |
|
213 |
199 |
$596.66 |
| 94060 |
|
15 |
14 |
$539.92 |
| 90619 |
|
55 |
55 |
$463.13 |
| 90381 |
|
44 |
44 |
$404.99 |
| 99058 |
|
15 |
15 |
$255.18 |
| 90685 |
|
43 |
43 |
$243.96 |
| 90688 |
|
31 |
31 |
$184.04 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15 |
14 |
$171.73 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
14 |
$152.03 |
| 96160 |
|
25 |
25 |
$66.00 |
| 99173 |
|
12 |
12 |
$36.00 |
| S9441 |
Asthma education, non-physician provider, per session |
17 |
14 |
$0.17 |
| 96127 |
|
64 |
55 |
$0.00 |
| 1031F |
|
15 |
13 |
$0.00 |
| 91307 |
|
39 |
20 |
$0.00 |
| G9920 |
Screening performed and negative |
1,350 |
958 |
$0.00 |
| G9359 |
Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier |
58 |
55 |
$0.00 |